Drew A. Torigian
Papers
2
Total Citations
10
H-Index
2
About
Drew A. Torigian is a leading researcher in the field of radiomics and medical imaging, with a primary focus on prostate cancer and its associated complications. His work centers on leveraging advanced MRI-based radiomic analysis to extract quantitative imaging features that can predict clinical outcomes. A major contribution is his pioneering use of periprostatic adipose tissue (PPAT) radiomics to identify features linked to clinically significant prostate cancer, demonstrating how altered lipid metabolism can be captured non-invasively through imaging. This study has garnered 7 citations and highlights the potential of radiomics to uncover novel biomarkers. Additionally, Torigian has explored the role of the levator ani muscle in post-prostatectomy urinary incontinence, using MRI-derived radiomic features to predict patient outcomes after robot-assisted radical prostatectomy—a study with 3 citations that addresses a critical quality-of-life issue. His work bridges the gap between imaging and personalized medicine, offering tools for risk stratification and treatment planning. Torigian’s research is notable for its translational impact, aiming to improve diagnostic accuracy and therapeutic decision-making in oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2